Heron Therapeutics, Inc. (HRTX) vs InterCure Ltd. (INCR)
A side-by-side comparison of Heron Therapeutics, Inc. and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HRTX
Heron Therapeutics, Inc.
$0.33HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
INCR
InterCure Ltd.
$5.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HRTX vs INCR
growth of $100 · dividends reinvested · last 8yHRTX -98.6% (-41.5%/yr)INCR -68.0% (-13.3%/yr)INCR compounded faster over this window
Log scale — wide-divergence pair
HRTX INCR
HRTX vs INCR: by the numbers
- •INCR is the larger company ($63M vs $63M market cap).
- •Both run net losses; INCR's is the smaller (-13.72% vs -22.52% net margin).
- •INCR grew revenue faster over the past five years (32.71% vs 12.73% CAGR).
Metrics side by side
Valuation
| Metric | HRTX | INCR |
|---|---|---|
| P/S ratio | 0.42 | 0.79 |
| P/B ratio | 10.72 | 0.51 |
| FCF yield | N/A | 11.66% |
Profitability
| Metric | HRTX | INCR |
|---|---|---|
| Gross margin | 70.07% | 14.40% |
| Operating margin | -7.19% | 2.49% |
| Net margin | -22.52% | -13.72% |
| ROE | -492.89% | -8.80% |
| ROIC | -6.79% | -4.72% |
Growth (annualized)
| Metric | HRTX | INCR |
|---|---|---|
| Revenue CAGR (5Y) | 12.73% | 32.71% |
| Total return CAGR (5Y) | -48.61% | -30.85% |
Frequently asked
- Which has grown faster, HRTX or INCR?
- Over the past five years, INCR grew revenue faster — HRTX at a 12.73% CAGR versus INCR at 32.71%.
- How have HRTX and INCR total returns compared?
- Over the past 5 years, HRTX delivered -48.61% and INCR delivered -30.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Heron Therapeutics ROEInterCure ROEHeron Therapeutics operating marginInterCure operating marginHeron Therapeutics revenue growthInterCure revenue growthHeron Therapeutics free cash flowInterCure free cash flow
Heron Therapeutics & InterCure appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.